ATOSSA THERAPEUTICS, INC. Option Indexed to Issuer's Equity, Indexed Shares
ATOSSA THERAPEUTICS, INC. (ATOS) had Option Indexed to Issuer's Equity, Indexed Shares of 325.00 thousand shares as of 2012-09-30, per its 10-Q filed 2014-05-14.
Discontinued › Notes › Other Liabilities
us-gaap:OptionIndexedToIssuersEquityIndexedShares · last filed 2014-05-14
- 2012-09-30: Option Indexed to Issuer's Equity, Indexed Shares 325.00K shares.
| Period end | Option Indexed to Issuer's Equity, Indexed Shares |
|---|---|
| 2012-09-30 | 325.00K shares 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |